- Evolving how English courts construe written commercial contracts (Teva v AstraZeneca)
- Original news
- What is the significance of this case?
- What was the case about?
- What was the decision?
- How has the way in which English courts construe written commercial contracts changed?
- What is the significance of the decision?
- Could AstraZeneca have avoided the issue?
- What are the practical implications of the judgment for practitioners?
Dispute Resolution analysis: Matthew Warren, partner at Bristows LLP and head of the firm’s commercial IP group, advises that Teva v AstraZeneca reinforces the necessity for practitioners engaged in negotiating and drafting commercial contracts to achieve clarity, avoid ambiguity and to cover reasonably foreseeable potential future scenarios.
Sign in or take a trial to read the full analysis.
To continue reading this news article, as well as thousands of others like it, sign in to LexisPSL or register for a free trial